Spinal Tumor Clinical Trials
The following trials for the treatment of various spinal cancer conditions are available for your participation. Click on the study number to view details of eligibility criteria.
Last updated 7/05/13
CERN09-02: Phase II trial of carboplatin and bevacizumab for the treatment of recurrent low-grade and anaplastic supratentorial, infratentorial and spinal cord ependymoma in adults
Principal Investigator: Mark R. Gilbert, M.D.
The goal of this clinical research study is to learn if the combination of bevacizumab and carboplatin can help to control recurrent ependymoma. The safety of this drug combination will also be studied.
Treatment at MD Anderson
Brain tumors, spinal tumors and skull base tumors are treated in our:
- Brain & Spine Center by our expert team.
Diseases We Treat
Q&A: Neuropsychology and its role in cancer care
More on basics, diagnosis and treatments:
Related Departments
Related Programs
News & Features
Q&A: Neuropsychology and its role in cancer care
A Neuropsychological Evaluation in Cancer Care
Addressing Emerging Survivorship Issues in Glioblastoma Patients
Bevacizumab offers no benefit for newly diagnosed glioblastoma, MD Anderson-led study finds
Test helps target glioblastoma patients most likely to benefit from bevacizumab
Q&A: Understanding glioblastoma
Researchers use cold virus to treat brain cancer (ABC News)
Brain cancer: A dream come true
A musician writes his first song after brain surgery
Hands-on environment to test surgical skills
Navigating a brain tumor: Cry, love and share
Follow Us
